Pharma & Healthcare
Global Human Coagulation Factor VIII Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 298167
- Pages: 173
- Figures: 180
- Views: 33
In 2024, the global market size of Human Coagulation Factor VIII was estimated to be worth US$ 11550 million and is forecast to reach approximately US$ 17610 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Market Drivers:
The increasing prevalence of hemophilia A is a key driver for the Human Coagulation Factor VIII market. As awareness and diagnosis rates improve, more patients are receiving proper treatment, driving demand for Factor VIII therapies. Additionally, advancements in biotechnology, including the development of recombinant and extended half-life Factor VIII products, have significantly improved treatment efficacy and patient convenience. Government initiatives and healthcare programs supporting rare disease treatments, along with expanded access to hemophilia care in developing regions, further boost market growth. The rise of gene therapy research also presents potential future opportunities for transforming the hemophilia treatment landscape.
Market Challenges:
Despite strong market growth, several challenges persist, including the high cost of Factor VIII therapies, which limits affordability and accessibility for many patients, especially in low-income regions. Additionally, plasma-derived Factor VIII products face supply chain constraints due to reliance on blood donations. Another major challenge is the development of inhibitors (antibodies) in some patients, which can render Factor VIII treatment ineffective and necessitate alternative therapies. Regulatory complexities and the need for stringent quality control in manufacturing also pose barriers for new entrants in the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
SinoCellTech
Taibang Bio
Huarun Boya
Shuanglin Bio
Yuandashuyang
Weiguang Bio
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Coagulation Factor VIII in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VIII sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Market Drivers:
The increasing prevalence of hemophilia A is a key driver for the Human Coagulation Factor VIII market. As awareness and diagnosis rates improve, more patients are receiving proper treatment, driving demand for Factor VIII therapies. Additionally, advancements in biotechnology, including the development of recombinant and extended half-life Factor VIII products, have significantly improved treatment efficacy and patient convenience. Government initiatives and healthcare programs supporting rare disease treatments, along with expanded access to hemophilia care in developing regions, further boost market growth. The rise of gene therapy research also presents potential future opportunities for transforming the hemophilia treatment landscape.
Market Challenges:
Despite strong market growth, several challenges persist, including the high cost of Factor VIII therapies, which limits affordability and accessibility for many patients, especially in low-income regions. Additionally, plasma-derived Factor VIII products face supply chain constraints due to reliance on blood donations. Another major challenge is the development of inhibitors (antibodies) in some patients, which can render Factor VIII treatment ineffective and necessitate alternative therapies. Regulatory complexities and the need for stringent quality control in manufacturing also pose barriers for new entrants in the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
SinoCellTech
Taibang Bio
Huarun Boya
Shuanglin Bio
Yuandashuyang
Weiguang Bio
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Coagulation Factor VIII in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VIII sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Human Coagulation Factor VIII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts
2.1.1 Global Human Coagulation Factor VIII Revenue 2020-2031
2.1.2 Global Human Coagulation Factor VIII Sales 2020-2031
2.2 Human Coagulation Factor VIII Market Size by Region: 2024 Versus 2031
2.3 Human Coagulation Factor VIII Sales by Region (2020-2031)
2.3.1 Global Human Coagulation Factor VIII Sales by Region: 2020-2025
2.3.2 Global Human Coagulation Factor VIII Sales Forecast by Region (2026-2031)
2.3.3 Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2031)
2.4 Human Coagulation Factor VIII Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Coagulation Factor VIII Revenue by Region: 2020-2025
2.4.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Coagulation Factor VIII Sales by Type (2020-2031)
3.1.1.1 Global Human Coagulation Factor VIII Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2031)
3.1.2 Global Human Coagulation Factor VIII Revenue by Type (2020-2031)
3.1.2.1 Global Human Coagulation Factor VIII Revenue by Type (2020-2031)
3.1.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2031)
3.1.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Coagulation Factor VIII Sales by Application (2020-2031)
3.2.1.1 Global Human Coagulation Factor VIII Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Coagulation Factor VIII Sales Market Share by Application (2020-2031)
3.2.2 Global Human Coagulation Factor VIII Revenue by Application (2020-2031)
3.2.2.1 Global Human Coagulation Factor VIII Revenue by Application (2020-2031)
3.2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2020-2031)
3.2.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Recombinant Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application
3.3.2 Plasma-derived Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application
4 Global Human Coagulation Factor VIII by Manufacturers
4.1 Global Top Human Coagulation Factor VIII Manufacturers by Sales (2020-2025)
4.1.1 Global Human Coagulation Factor VIII Sales by Manufacturer (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Coagulation Factor VIII Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Coagulation Factor VIII Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Coagulation Factor VIII Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Coagulation Factor VIII Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Coagulation Factor VIII Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Coagulation Factor VIII Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Product Type
4.5.1 Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Coagulation Factor VIII Market
4.5.3 Manufacturers Human Coagulation Factor VIII Product Type and Application
4.5.4 Recombinant Factor VIII Market Sales of Human Coagulation Factor VIII by Manufacturer
4.5.5 Plasma-derived Factor VIII Market Sales of Human Coagulation Factor VIII by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Shire (Baxter)
5.1.1 Shire (Baxter) Company Information
5.1.2 Shire (Baxter) Description, Business Overview
5.1.3 Shire (Baxter) Human Coagulation Factor VIII Products Offered
5.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Shire (Baxter) Human Coagulation Factor VIII Sales by Product in 2024
5.1.6 Shire (Baxter) Human Coagulation Factor VIII Sales by Application in 2024
5.1.7 Shire (Baxter) Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.1.8 Shire (Baxter) Recent Developments
5.2 Bayer
5.2.1 Bayer Company Information
5.2.2 Bayer Description, Business Overview
5.2.3 Bayer Human Coagulation Factor VIII Products Offered
5.2.4 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Bayer Human Coagulation Factor VIII Sales by Product in 2024
5.2.6 Bayer Human Coagulation Factor VIII Sales by Application in 2024
5.2.7 Bayer Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.2.8 Bayer Recent Developments
5.3 CSL
5.3.1 CSL Company Information
5.3.2 CSL Description, Business Overview
5.3.3 CSL Human Coagulation Factor VIII Products Offered
5.3.4 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.3.5 CSL Human Coagulation Factor VIII Sales by Product in 2024
5.3.6 CSL Human Coagulation Factor VIII Sales by Application in 2024
5.3.7 CSL Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.3.8 CSL Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Human Coagulation Factor VIII Products Offered
5.4.4 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Human Coagulation Factor VIII Sales by Product in 2024
5.4.6 Pfizer Human Coagulation Factor VIII Sales by Application in 2024
5.4.7 Pfizer Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Grifols
5.5.1 Grifols Company Information
5.5.2 Grifols Description, Business Overview
5.5.3 Grifols Human Coagulation Factor VIII Products Offered
5.5.4 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Grifols Human Coagulation Factor VIII Sales by Product in 2024
5.5.6 Grifols Human Coagulation Factor VIII Sales by Application in 2024
5.5.7 Grifols Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.5.8 Grifols Recent Developments
5.6 Biogen
5.6.1 Biogen Company Information
5.6.2 Biogen Description, Business Overview
5.6.3 Biogen Human Coagulation Factor VIII Products Offered
5.6.4 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Biogen Human Coagulation Factor VIII Sales by Product in 2024
5.6.6 Biogen Human Coagulation Factor VIII Sales by Application in 2024
5.6.7 Biogen Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.6.8 Biogen Recent Developments
5.7 Octapharma
5.7.1 Octapharma Company Information
5.7.2 Octapharma Description, Business Overview
5.7.3 Octapharma Human Coagulation Factor VIII Products Offered
5.7.4 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Octapharma Human Coagulation Factor VIII Sales by Product in 2024
5.7.6 Octapharma Human Coagulation Factor VIII Sales by Application in 2024
5.7.7 Octapharma Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.7.8 Octapharma Recent Developments
5.8 NovoNordisk
5.8.1 NovoNordisk Company Information
5.8.2 NovoNordisk Description, Business Overview
5.8.3 NovoNordisk Human Coagulation Factor VIII Products Offered
5.8.4 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.8.5 NovoNordisk Human Coagulation Factor VIII Sales by Product in 2024
5.8.6 NovoNordisk Human Coagulation Factor VIII Sales by Application in 2024
5.8.7 NovoNordisk Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.8.8 NovoNordisk Recent Developments
5.9 Greencross
5.9.1 Greencross Company Information
5.9.2 Greencross Description, Business Overview
5.9.3 Greencross Human Coagulation Factor VIII Products Offered
5.9.4 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Greencross Human Coagulation Factor VIII Sales by Product in 2024
5.9.6 Greencross Human Coagulation Factor VIII Sales by Application in 2024
5.9.7 Greencross Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.9.8 Greencross Recent Developments
5.10 Kedrion
5.10.1 Kedrion Company Information
5.10.2 Kedrion Description, Business Overview
5.10.3 Kedrion Human Coagulation Factor VIII Products Offered
5.10.4 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Kedrion Human Coagulation Factor VIII Sales by Product in 2024
5.10.6 Kedrion Human Coagulation Factor VIII Sales by Application in 2024
5.10.7 Kedrion Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.10.8 Kedrion Recent Developments
5.11 BPL
5.11.1 BPL Company Information
5.11.2 BPL Description, Business Overview
5.11.3 BPL Human Coagulation Factor VIII Products Offered
5.11.4 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.11.5 BPL Human Coagulation Factor VIII Sales by Product in 2024
5.11.6 BPL Human Coagulation Factor VIII Sales by Application in 2024
5.11.7 BPL Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.11.8 BPL Recent Developments
5.12 Hualan Bio
5.12.1 Hualan Bio Company Information
5.12.2 Hualan Bio Description, Business Overview
5.12.3 Hualan Bio Human Coagulation Factor VIII Products Offered
5.12.4 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Hualan Bio Human Coagulation Factor VIII Sales by Product in 2024
5.12.6 Hualan Bio Human Coagulation Factor VIII Sales by Application in 2024
5.12.7 Hualan Bio Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.12.8 Hualan Bio Recent Developments
5.13 RAAS
5.13.1 RAAS Company Information
5.13.2 RAAS Description, Business Overview
5.13.3 RAAS Human Coagulation Factor VIII Products Offered
5.13.4 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.13.5 RAAS Human Coagulation Factor VIII Sales by Product in 2024
5.13.6 RAAS Human Coagulation Factor VIII Sales by Application in 2024
5.13.7 RAAS Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.13.8 RAAS Recent Developments
6 North America
6.1 North America Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
6.2 North America Human Coagulation Factor VIII Market Facts & Figures by Country
6.2.1 North America Human Coagulation Factor VIII Sales by Country (2020-2031)
6.2.2 North America Human Coagulation Factor VIII Revenue by Country (2020-2031)
6.3 North America Human Coagulation Factor VIII Sales by Type (2020-2025)
6.4 North America Human Coagulation Factor VIII Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Coagulation Factor VIII Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Coagulation Factor VIII Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Coagulation Factor VIII Sales by Type (2020-2025)
7.4 Asia-Pacific Human Coagulation Factor VIII Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
8.2 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
8.2.1 Europe Human Coagulation Factor VIII Sales by Country (2020-2031)
8.2.2 Europe Human Coagulation Factor VIII Revenue by Country (2020-2031)
8.3 Europe Human Coagulation Factor VIII Sales by Type (2020-2025)
8.4 Europe Human Coagulation Factor VIII Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
9.2 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
9.2.1 Latin America Human Coagulation Factor VIII Sales by Country (2020-2031)
9.2.2 Latin America Human Coagulation Factor VIII Revenue by Country (2020-2031)
9.3 Latin America Human Coagulation Factor VIII Sales by Type (2020-2025)
9.4 Latin America Human Coagulation Factor VIII Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Coagulation Factor VIII Sales by Type (2020-2025)
10.4 Middle East and Africa Human Coagulation Factor VIII Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Coagulation Factor VIII Supply Chain Analysis
11.2 Human Coagulation Factor VIII Key Raw Materials and Upstream Suppliers
11.3 Human Coagulation Factor VIII Clients Analysis
11.4 Human Coagulation Factor VIII Sales Channel and Sales Model Analysis
11.4.1 Human Coagulation Factor VIII Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Coagulation Factor VIII Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Coagulation Factor VIII Distributors
12 Human Coagulation Factor VIII Market Dynamics
12.1 Human Coagulation Factor VIII Industry Trends
12.2 Human Coagulation Factor VIII Market Drivers
12.3 Human Coagulation Factor VIII Market Challenges
12.4 Human Coagulation Factor VIII Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Human Coagulation Factor VIII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts
2.1.1 Global Human Coagulation Factor VIII Revenue 2020-2031
2.1.2 Global Human Coagulation Factor VIII Sales 2020-2031
2.2 Human Coagulation Factor VIII Market Size by Region: 2024 Versus 2031
2.3 Human Coagulation Factor VIII Sales by Region (2020-2031)
2.3.1 Global Human Coagulation Factor VIII Sales by Region: 2020-2025
2.3.2 Global Human Coagulation Factor VIII Sales Forecast by Region (2026-2031)
2.3.3 Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2031)
2.4 Human Coagulation Factor VIII Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Coagulation Factor VIII Revenue by Region: 2020-2025
2.4.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Coagulation Factor VIII Sales by Type (2020-2031)
3.1.1.1 Global Human Coagulation Factor VIII Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2031)
3.1.2 Global Human Coagulation Factor VIII Revenue by Type (2020-2031)
3.1.2.1 Global Human Coagulation Factor VIII Revenue by Type (2020-2031)
3.1.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2031)
3.1.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Coagulation Factor VIII Sales by Application (2020-2031)
3.2.1.1 Global Human Coagulation Factor VIII Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Coagulation Factor VIII Sales Market Share by Application (2020-2031)
3.2.2 Global Human Coagulation Factor VIII Revenue by Application (2020-2031)
3.2.2.1 Global Human Coagulation Factor VIII Revenue by Application (2020-2031)
3.2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2020-2031)
3.2.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Recombinant Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application
3.3.2 Plasma-derived Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application
4 Global Human Coagulation Factor VIII by Manufacturers
4.1 Global Top Human Coagulation Factor VIII Manufacturers by Sales (2020-2025)
4.1.1 Global Human Coagulation Factor VIII Sales by Manufacturer (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Coagulation Factor VIII Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Coagulation Factor VIII Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Coagulation Factor VIII Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Coagulation Factor VIII Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Coagulation Factor VIII Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Coagulation Factor VIII Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Product Type
4.5.1 Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Coagulation Factor VIII Market
4.5.3 Manufacturers Human Coagulation Factor VIII Product Type and Application
4.5.4 Recombinant Factor VIII Market Sales of Human Coagulation Factor VIII by Manufacturer
4.5.5 Plasma-derived Factor VIII Market Sales of Human Coagulation Factor VIII by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Shire (Baxter)
5.1.1 Shire (Baxter) Company Information
5.1.2 Shire (Baxter) Description, Business Overview
5.1.3 Shire (Baxter) Human Coagulation Factor VIII Products Offered
5.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Shire (Baxter) Human Coagulation Factor VIII Sales by Product in 2024
5.1.6 Shire (Baxter) Human Coagulation Factor VIII Sales by Application in 2024
5.1.7 Shire (Baxter) Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.1.8 Shire (Baxter) Recent Developments
5.2 Bayer
5.2.1 Bayer Company Information
5.2.2 Bayer Description, Business Overview
5.2.3 Bayer Human Coagulation Factor VIII Products Offered
5.2.4 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Bayer Human Coagulation Factor VIII Sales by Product in 2024
5.2.6 Bayer Human Coagulation Factor VIII Sales by Application in 2024
5.2.7 Bayer Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.2.8 Bayer Recent Developments
5.3 CSL
5.3.1 CSL Company Information
5.3.2 CSL Description, Business Overview
5.3.3 CSL Human Coagulation Factor VIII Products Offered
5.3.4 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.3.5 CSL Human Coagulation Factor VIII Sales by Product in 2024
5.3.6 CSL Human Coagulation Factor VIII Sales by Application in 2024
5.3.7 CSL Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.3.8 CSL Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Human Coagulation Factor VIII Products Offered
5.4.4 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Human Coagulation Factor VIII Sales by Product in 2024
5.4.6 Pfizer Human Coagulation Factor VIII Sales by Application in 2024
5.4.7 Pfizer Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Grifols
5.5.1 Grifols Company Information
5.5.2 Grifols Description, Business Overview
5.5.3 Grifols Human Coagulation Factor VIII Products Offered
5.5.4 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Grifols Human Coagulation Factor VIII Sales by Product in 2024
5.5.6 Grifols Human Coagulation Factor VIII Sales by Application in 2024
5.5.7 Grifols Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.5.8 Grifols Recent Developments
5.6 Biogen
5.6.1 Biogen Company Information
5.6.2 Biogen Description, Business Overview
5.6.3 Biogen Human Coagulation Factor VIII Products Offered
5.6.4 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Biogen Human Coagulation Factor VIII Sales by Product in 2024
5.6.6 Biogen Human Coagulation Factor VIII Sales by Application in 2024
5.6.7 Biogen Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.6.8 Biogen Recent Developments
5.7 Octapharma
5.7.1 Octapharma Company Information
5.7.2 Octapharma Description, Business Overview
5.7.3 Octapharma Human Coagulation Factor VIII Products Offered
5.7.4 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Octapharma Human Coagulation Factor VIII Sales by Product in 2024
5.7.6 Octapharma Human Coagulation Factor VIII Sales by Application in 2024
5.7.7 Octapharma Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.7.8 Octapharma Recent Developments
5.8 NovoNordisk
5.8.1 NovoNordisk Company Information
5.8.2 NovoNordisk Description, Business Overview
5.8.3 NovoNordisk Human Coagulation Factor VIII Products Offered
5.8.4 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.8.5 NovoNordisk Human Coagulation Factor VIII Sales by Product in 2024
5.8.6 NovoNordisk Human Coagulation Factor VIII Sales by Application in 2024
5.8.7 NovoNordisk Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.8.8 NovoNordisk Recent Developments
5.9 Greencross
5.9.1 Greencross Company Information
5.9.2 Greencross Description, Business Overview
5.9.3 Greencross Human Coagulation Factor VIII Products Offered
5.9.4 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Greencross Human Coagulation Factor VIII Sales by Product in 2024
5.9.6 Greencross Human Coagulation Factor VIII Sales by Application in 2024
5.9.7 Greencross Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.9.8 Greencross Recent Developments
5.10 Kedrion
5.10.1 Kedrion Company Information
5.10.2 Kedrion Description, Business Overview
5.10.3 Kedrion Human Coagulation Factor VIII Products Offered
5.10.4 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Kedrion Human Coagulation Factor VIII Sales by Product in 2024
5.10.6 Kedrion Human Coagulation Factor VIII Sales by Application in 2024
5.10.7 Kedrion Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.10.8 Kedrion Recent Developments
5.11 BPL
5.11.1 BPL Company Information
5.11.2 BPL Description, Business Overview
5.11.3 BPL Human Coagulation Factor VIII Products Offered
5.11.4 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.11.5 BPL Human Coagulation Factor VIII Sales by Product in 2024
5.11.6 BPL Human Coagulation Factor VIII Sales by Application in 2024
5.11.7 BPL Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.11.8 BPL Recent Developments
5.12 Hualan Bio
5.12.1 Hualan Bio Company Information
5.12.2 Hualan Bio Description, Business Overview
5.12.3 Hualan Bio Human Coagulation Factor VIII Products Offered
5.12.4 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Hualan Bio Human Coagulation Factor VIII Sales by Product in 2024
5.12.6 Hualan Bio Human Coagulation Factor VIII Sales by Application in 2024
5.12.7 Hualan Bio Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.12.8 Hualan Bio Recent Developments
5.13 RAAS
5.13.1 RAAS Company Information
5.13.2 RAAS Description, Business Overview
5.13.3 RAAS Human Coagulation Factor VIII Products Offered
5.13.4 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
5.13.5 RAAS Human Coagulation Factor VIII Sales by Product in 2024
5.13.6 RAAS Human Coagulation Factor VIII Sales by Application in 2024
5.13.7 RAAS Human Coagulation Factor VIII Sales by Geographic Area in 2024
5.13.8 RAAS Recent Developments
6 North America
6.1 North America Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
6.2 North America Human Coagulation Factor VIII Market Facts & Figures by Country
6.2.1 North America Human Coagulation Factor VIII Sales by Country (2020-2031)
6.2.2 North America Human Coagulation Factor VIII Revenue by Country (2020-2031)
6.3 North America Human Coagulation Factor VIII Sales by Type (2020-2025)
6.4 North America Human Coagulation Factor VIII Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Coagulation Factor VIII Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Coagulation Factor VIII Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Coagulation Factor VIII Sales by Type (2020-2025)
7.4 Asia-Pacific Human Coagulation Factor VIII Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
8.2 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
8.2.1 Europe Human Coagulation Factor VIII Sales by Country (2020-2031)
8.2.2 Europe Human Coagulation Factor VIII Revenue by Country (2020-2031)
8.3 Europe Human Coagulation Factor VIII Sales by Type (2020-2025)
8.4 Europe Human Coagulation Factor VIII Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
9.2 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
9.2.1 Latin America Human Coagulation Factor VIII Sales by Country (2020-2031)
9.2.2 Latin America Human Coagulation Factor VIII Revenue by Country (2020-2031)
9.3 Latin America Human Coagulation Factor VIII Sales by Type (2020-2025)
9.4 Latin America Human Coagulation Factor VIII Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Coagulation Factor VIII Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Coagulation Factor VIII Sales by Type (2020-2025)
10.4 Middle East and Africa Human Coagulation Factor VIII Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Coagulation Factor VIII Supply Chain Analysis
11.2 Human Coagulation Factor VIII Key Raw Materials and Upstream Suppliers
11.3 Human Coagulation Factor VIII Clients Analysis
11.4 Human Coagulation Factor VIII Sales Channel and Sales Model Analysis
11.4.1 Human Coagulation Factor VIII Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Coagulation Factor VIII Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Coagulation Factor VIII Distributors
12 Human Coagulation Factor VIII Market Dynamics
12.1 Human Coagulation Factor VIII Industry Trends
12.2 Human Coagulation Factor VIII Market Drivers
12.3 Human Coagulation Factor VIII Market Challenges
12.4 Human Coagulation Factor VIII Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Coagulation Factor VIII Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Sales Forecast by Region (2026-2031) & (K Bottles)
Table 6. Global Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Human Coagulation Factor VIII Sales Volume by Type (2020-2025) & (K Bottles)
Table 9. Global Human Coagulation Factor VIII Sales Volume by Type (2026-2031) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Human Coagulation Factor VIII Sales Volume by Application (2020-2025) & (K Bottles)
Table 13. Global Human Coagulation Factor VIII Sales Volume by Application (2026-2031) & (K Bottles)
Table 14. Global Human Coagulation Factor VIII Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Human Coagulation Factor VIII Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Human Coagulation Factor VIII Sales by Manufacturer (2020-2025) & (K Bottles)
Table 17. Global Human Coagulation Factor VIII Sales Share by Manufacturer (2020-2025)
Table 18. Human Coagulation Factor VIII Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Human Coagulation Factor VIII Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Human Coagulation Factor VIII Price (2020-2025) & (USD/Bottle)
Table 21. Ranking of Global Top Human Coagulation Factor VIII Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
Table 24. Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Human Coagulation Factor VIII Market
Table 26. Manufacturers Human Coagulation Factor VIII Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Shire (Baxter) Company Information
Table 29. Shire (Baxter) Description and Business Overview
Table 30. Shire (Baxter) Human Coagulation Factor VIII Product
Table 31. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 32. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 33. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 34. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 35. Shire (Baxter) Recent Developments
Table 36. Bayer Company Information
Table 37. Bayer Description and Business Overview
Table 38. Bayer Human Coagulation Factor VIII Product
Table 39. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 40. Bayer Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 41. Bayer Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 42. Bayer Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 43. Bayer Recent Developments
Table 44. CSL Company Information
Table 45. CSL Description and Business Overview
Table 46. CSL Human Coagulation Factor VIII Product
Table 47. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 48. CSL Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 49. CSL Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 50. CSL Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 51. CSL Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Human Coagulation Factor VIII Product
Table 55. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 57. Pfizer Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 58. Pfizer Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. Grifols Company Information
Table 61. Grifols Description and Business Overview
Table 62. Grifols Human Coagulation Factor VIII Product
Table 63. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 64. Grifols Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 65. Grifols Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 66. Grifols Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 67. Grifols Recent Developments
Table 68. Biogen Company Information
Table 69. Biogen Description and Business Overview
Table 70. Biogen Human Coagulation Factor VIII Product
Table 71. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 72. Biogen Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 73. Biogen Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 74. Biogen Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 75. Biogen Recent Developments
Table 76. Octapharma Company Information
Table 77. Octapharma Description and Business Overview
Table 78. Octapharma Human Coagulation Factor VIII Product
Table 79. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 80. Octapharma Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 81. Octapharma Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 82. Octapharma Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 83. Octapharma Recent Developments
Table 84. NovoNordisk Company Information
Table 85. NovoNordisk Description and Business Overview
Table 86. NovoNordisk Human Coagulation Factor VIII Product
Table 87. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 88. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 89. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 90. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 91. NovoNordisk Recent Developments
Table 92. Greencross Company Information
Table 93. Greencross Description and Business Overview
Table 94. Greencross Human Coagulation Factor VIII Product
Table 95. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 96. Greencross Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 97. Greencross Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 98. Greencross Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 99. Greencross Recent Developments
Table 100. Kedrion Company Information
Table 101. Kedrion Description and Business Overview
Table 102. Kedrion Human Coagulation Factor VIII Product
Table 103. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 104. Kedrion Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 105. Kedrion Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 106. Kedrion Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 107. Kedrion Recent Developments
Table 108. BPL Company Information
Table 109. BPL Description and Business Overview
Table 110. BPL Human Coagulation Factor VIII Product
Table 111. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 112. BPL Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 113. BPL Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 114. BPL Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 115. BPL Recent Developments
Table 116. Hualan Bio Company Information
Table 117. Hualan Bio Description and Business Overview
Table 118. Hualan Bio Human Coagulation Factor VIII Product
Table 119. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 120. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 121. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 122. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 123. Hualan Bio Recent Developments
Table 124. RAAS Company Information
Table 125. RAAS Description and Business Overview
Table 126. RAAS Human Coagulation Factor VIII Product
Table 127. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 128. RAAS Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 129. RAAS Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 130. RAAS Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 131. RAAS Recent Developments
Table 132. North America Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 133. North America Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 134. North America Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 135. North America Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 136. North America Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 137. North America Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 138. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
Table 139. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2026-2031) & (K Bottles)
Table 140. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 141. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 142. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 143. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 144. Europe Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 145. Europe Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 146. Europe Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 147. Europe Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 148. Europe Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 149. Europe Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 150. Latin America Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 151. Latin America Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 152. Latin America Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 153. Latin America Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 154. Latin America Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 155. Latin America Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 156. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 157. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 158. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 159. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 160. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 161. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 162. Human Coagulation Factor VIII Key Raw Materials, Industry Status and Trend
Table 163. Human Coagulation Factor VIII Key Raw Materials and Upstream Suppliers
Table 164. Human Coagulation Factor VIII Clients Status and Trend
Table 165. Human Coagulation Factor VIII Typical Clients
Table 166. Human Coagulation Factor VIII Distributors
Table 167. Human Coagulation Factor VIII Market Trends
Table 168. Human Coagulation Factor VIII Market Drivers
Table 169. Human Coagulation Factor VIII Market Challenges
Table 170. Human Coagulation Factor VIII Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Coagulation Factor VIII Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant Factor VIII Product Picture
Figure 5. Plasma-derived Factor VIII Product Picture
Figure 6. Global Human Coagulation Factor VIII Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Human Coagulation Factor VIII Sales Market Share by Application in 2024 & 2031
Figure 8. Hemophilia A
Figure 9. Spontanous / Trauma
Figure 10. Surgical
Figure 11. Other
Figure 12. Human Coagulation Factor VIII Report Years Considered
Figure 13. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Coagulation Factor VIII Market Size 2020-2031 (US$ Million)
Figure 15. Global Human Coagulation Factor VIII Sales 2020-2031 (K Bottles)
Figure 16. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
Figure 18. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2020-2025) & (USD/Bottle)
Figure 21. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2020-2025) & (USD/Bottle)
Figure 24. Recombinant Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application, 2024 VS 2031
Figure 25. Plasma-derived Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Human Coagulation Factor VIII Sales Share by Manufacturer in 2024
Figure 27. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Recombinant Factor VIII Market Sales Proportion by Manufacturer in 2024
Figure 29. Plasma-derived Factor VIII Market Sales Proportion by Manufacturer in 2024
Figure 30. North America Human Coagulation Factor VIII Revenue 2020-2031 (US$ Million)
Figure 31. North America Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 32. North America Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Human Coagulation Factor VIII Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 37. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 38. Europe Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Europe Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
Figure 40. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
Figure 41. Europe Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 42. Europe Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 43. Latin America Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
Figure 45. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Figure 46. Latin America Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 47. Latin America Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 48. Middle East and Africa Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 52. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 53. Human Coagulation Factor VIII Supply Chain (Upstream and Downstream Market)
Figure 54. Global Production Market Share of Human Coagulation Factor VIII Raw Materials by Region in 2024
Figure 55. Human Coagulation Factor VIII Distribution Channels
Figure 56. Global Human Coagulation Factor VIII Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 57. Global Human Coagulation Factor VIII Percentage 2020-2031: Online Sales VS Offline Sales
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Coagulation Factor VIII Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Sales Forecast by Region (2026-2031) & (K Bottles)
Table 6. Global Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Human Coagulation Factor VIII Sales Volume by Type (2020-2025) & (K Bottles)
Table 9. Global Human Coagulation Factor VIII Sales Volume by Type (2026-2031) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Human Coagulation Factor VIII Sales Volume by Application (2020-2025) & (K Bottles)
Table 13. Global Human Coagulation Factor VIII Sales Volume by Application (2026-2031) & (K Bottles)
Table 14. Global Human Coagulation Factor VIII Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Human Coagulation Factor VIII Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Human Coagulation Factor VIII Sales by Manufacturer (2020-2025) & (K Bottles)
Table 17. Global Human Coagulation Factor VIII Sales Share by Manufacturer (2020-2025)
Table 18. Human Coagulation Factor VIII Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Human Coagulation Factor VIII Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Human Coagulation Factor VIII Price (2020-2025) & (USD/Bottle)
Table 21. Ranking of Global Top Human Coagulation Factor VIII Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
Table 24. Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Human Coagulation Factor VIII Market
Table 26. Manufacturers Human Coagulation Factor VIII Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Shire (Baxter) Company Information
Table 29. Shire (Baxter) Description and Business Overview
Table 30. Shire (Baxter) Human Coagulation Factor VIII Product
Table 31. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 32. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 33. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 34. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 35. Shire (Baxter) Recent Developments
Table 36. Bayer Company Information
Table 37. Bayer Description and Business Overview
Table 38. Bayer Human Coagulation Factor VIII Product
Table 39. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 40. Bayer Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 41. Bayer Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 42. Bayer Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 43. Bayer Recent Developments
Table 44. CSL Company Information
Table 45. CSL Description and Business Overview
Table 46. CSL Human Coagulation Factor VIII Product
Table 47. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 48. CSL Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 49. CSL Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 50. CSL Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 51. CSL Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Human Coagulation Factor VIII Product
Table 55. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 57. Pfizer Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 58. Pfizer Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. Grifols Company Information
Table 61. Grifols Description and Business Overview
Table 62. Grifols Human Coagulation Factor VIII Product
Table 63. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 64. Grifols Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 65. Grifols Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 66. Grifols Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 67. Grifols Recent Developments
Table 68. Biogen Company Information
Table 69. Biogen Description and Business Overview
Table 70. Biogen Human Coagulation Factor VIII Product
Table 71. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 72. Biogen Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 73. Biogen Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 74. Biogen Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 75. Biogen Recent Developments
Table 76. Octapharma Company Information
Table 77. Octapharma Description and Business Overview
Table 78. Octapharma Human Coagulation Factor VIII Product
Table 79. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 80. Octapharma Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 81. Octapharma Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 82. Octapharma Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 83. Octapharma Recent Developments
Table 84. NovoNordisk Company Information
Table 85. NovoNordisk Description and Business Overview
Table 86. NovoNordisk Human Coagulation Factor VIII Product
Table 87. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 88. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 89. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 90. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 91. NovoNordisk Recent Developments
Table 92. Greencross Company Information
Table 93. Greencross Description and Business Overview
Table 94. Greencross Human Coagulation Factor VIII Product
Table 95. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 96. Greencross Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 97. Greencross Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 98. Greencross Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 99. Greencross Recent Developments
Table 100. Kedrion Company Information
Table 101. Kedrion Description and Business Overview
Table 102. Kedrion Human Coagulation Factor VIII Product
Table 103. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 104. Kedrion Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 105. Kedrion Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 106. Kedrion Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 107. Kedrion Recent Developments
Table 108. BPL Company Information
Table 109. BPL Description and Business Overview
Table 110. BPL Human Coagulation Factor VIII Product
Table 111. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 112. BPL Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 113. BPL Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 114. BPL Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 115. BPL Recent Developments
Table 116. Hualan Bio Company Information
Table 117. Hualan Bio Description and Business Overview
Table 118. Hualan Bio Human Coagulation Factor VIII Product
Table 119. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 120. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 121. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 122. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 123. Hualan Bio Recent Developments
Table 124. RAAS Company Information
Table 125. RAAS Description and Business Overview
Table 126. RAAS Human Coagulation Factor VIII Product
Table 127. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 128. RAAS Sales Proportion of Human Coagulation Factor VIII by Product in 2024
Table 129. RAAS Sales Proportion of Human Coagulation Factor VIII by Application in 2024
Table 130. RAAS Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2024
Table 131. RAAS Recent Developments
Table 132. North America Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 133. North America Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 134. North America Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 135. North America Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 136. North America Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 137. North America Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 138. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
Table 139. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2026-2031) & (K Bottles)
Table 140. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 141. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 142. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 143. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 144. Europe Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 145. Europe Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 146. Europe Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 147. Europe Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 148. Europe Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 149. Europe Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 150. Latin America Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 151. Latin America Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 152. Latin America Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 153. Latin America Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 154. Latin America Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 155. Latin America Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 156. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 157. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
Table 158. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 159. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 160. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 161. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 162. Human Coagulation Factor VIII Key Raw Materials, Industry Status and Trend
Table 163. Human Coagulation Factor VIII Key Raw Materials and Upstream Suppliers
Table 164. Human Coagulation Factor VIII Clients Status and Trend
Table 165. Human Coagulation Factor VIII Typical Clients
Table 166. Human Coagulation Factor VIII Distributors
Table 167. Human Coagulation Factor VIII Market Trends
Table 168. Human Coagulation Factor VIII Market Drivers
Table 169. Human Coagulation Factor VIII Market Challenges
Table 170. Human Coagulation Factor VIII Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Coagulation Factor VIII Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant Factor VIII Product Picture
Figure 5. Plasma-derived Factor VIII Product Picture
Figure 6. Global Human Coagulation Factor VIII Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Human Coagulation Factor VIII Sales Market Share by Application in 2024 & 2031
Figure 8. Hemophilia A
Figure 9. Spontanous / Trauma
Figure 10. Surgical
Figure 11. Other
Figure 12. Human Coagulation Factor VIII Report Years Considered
Figure 13. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Coagulation Factor VIII Market Size 2020-2031 (US$ Million)
Figure 15. Global Human Coagulation Factor VIII Sales 2020-2031 (K Bottles)
Figure 16. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
Figure 18. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2020-2025) & (USD/Bottle)
Figure 21. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2020-2025) & (USD/Bottle)
Figure 24. Recombinant Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application, 2024 VS 2031
Figure 25. Plasma-derived Factor VIII of Human Coagulation Factor VIII Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Human Coagulation Factor VIII Sales Share by Manufacturer in 2024
Figure 27. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Recombinant Factor VIII Market Sales Proportion by Manufacturer in 2024
Figure 29. Plasma-derived Factor VIII Market Sales Proportion by Manufacturer in 2024
Figure 30. North America Human Coagulation Factor VIII Revenue 2020-2031 (US$ Million)
Figure 31. North America Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 32. North America Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Human Coagulation Factor VIII Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 37. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 38. Europe Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Europe Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
Figure 40. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
Figure 41. Europe Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 42. Europe Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 43. Latin America Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
Figure 45. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Figure 46. Latin America Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 47. Latin America Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 48. Middle East and Africa Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 52. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 53. Human Coagulation Factor VIII Supply Chain (Upstream and Downstream Market)
Figure 54. Global Production Market Share of Human Coagulation Factor VIII Raw Materials by Region in 2024
Figure 55. Human Coagulation Factor VIII Distribution Channels
Figure 56. Global Human Coagulation Factor VIII Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 57. Global Human Coagulation Factor VIII Percentage 2020-2031: Online Sales VS Offline Sales
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232